<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(10)</volume><submitter>Yin L</submitter><pubmed_abstract>Purinergic signaling plays a causal role in the modulation of immune inflammatory response in the course of psoriasis, but its regulatory mechanism remains unclear. As a member of purinoceptors, P2Y&lt;sub>6&lt;/sub>R mainly distributed in macrophages was significantly up-expressed in skin lesions from patients with psoriasis in the present study. Here, the severity of psoriasis was alleviated in imiquimod-treated mice with macrophages conditional knockout of P2Y&lt;sub>6&lt;/sub>R, while the cell-chat algorithm showed there was a correlation between macrophage P2Y&lt;sub>6&lt;/sub>R and Th1 cells mediated by IL-27. Mechanistically, P2Y&lt;sub>6&lt;/sub>R enhanced PLC &lt;sub>&lt;i>β&lt;/i>&lt;/sub> /p-PKC/MAPK activation to induce IL-27 release dependently, which subsequently regulated the differentiation of Th1 cells, lead</pubmed_abstract><journal>Acta pharmaceutica Sinica. B</journal><pagination>4360-4377</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11544167</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Macrophage P2Y&amp;lt;sub&amp;gt;6&amp;lt;/sub&amp;gt;R activation aggravates psoriatic inflammation through IL-27-mediated Th1 responses.</pubmed_title><pmcid>PMC11544167</pmcid><pubmed_authors>Zhou M</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Zhang E</pubmed_authors><pubmed_authors>Ni K</pubmed_authors><pubmed_authors>Mao T</pubmed_authors><pubmed_authors>Zhu Y</pubmed_authors><pubmed_authors>Lu Y</pubmed_authors><pubmed_authors>Ni S</pubmed_authors><pubmed_authors>Fang Y</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Hu Q</pubmed_authors><pubmed_authors>Yin L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Macrophage P2Y&amp;lt;sub&amp;gt;6&amp;lt;/sub&amp;gt;R activation aggravates psoriatic inflammation through IL-27-mediated Th1 responses.</name><description>Purinergic signaling plays a causal role in the modulation of immune inflammatory response in the course of psoriasis, but its regulatory mechanism remains unclear. As a member of purinoceptors, P2Y&lt;sub>6&lt;/sub>R mainly distributed in macrophages was significantly up-expressed in skin lesions from patients with psoriasis in the present study. Here, the severity of psoriasis was alleviated in imiquimod-treated mice with macrophages conditional knockout of P2Y&lt;sub>6&lt;/sub>R, while the cell-chat algorithm showed there was a correlation between macrophage P2Y&lt;sub>6&lt;/sub>R and Th1 cells mediated by IL-27. Mechanistically, P2Y&lt;sub>6&lt;/sub>R enhanced PLC &lt;sub>&lt;i>β&lt;/i>&lt;/sub> /p-PKC/MAPK activation to induce IL-27 release dependently, which subsequently regulated the differentiation of Th1 cells, lead</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2025-04-22T16:25:05.127Z</modification><creation>2025-04-06T01:45:20.727Z</creation></dates><accession>S-EPMC11544167</accession><cross_references><pubmed>39525587</pubmed><doi>10.1016/j.apsb.2024.06.008</doi></cross_references></HashMap>